Host-directed Therapy: A New Arsenal to Come

Area of Science:

• Microbiology
• Immunology
• Pharmacology

Background:

• Rising drug-resistant pathogens pose a significant global health threat, with limited success in developing new antibiotics.
• Intracellular pathogens manipulate host cell machinery, altering gene expression and suppressing innate defenses like apoptosis and autophagy.
• These pathogens co-evolve with hosts, employing molecular mimicry and immune evasion tactics to ensure survival and persistence.

Purpose of the Study:

• To explore Host-Directed Therapy (HDT) as a novel therapeutic strategy against intracellular pathogens.
• To investigate HDT's potential to overcome antibiotic resistance and chronic inflammation associated with infectious diseases.

Main Methods:

• Conceptual analysis of host-pathogen interactions and immune evasion mechanisms.
• Review of existing literature on Host-Directed Therapy (HDT) principles and applications.
• Exploration of HDT's potential to modulate host factors to inhibit pathogen replication and persistence.

Main Results:

• HDT targets host factors that are crucial for pathogen survival and replication within host cells.
• This strategy can abrogate pathogen persistence and enhance the host's antimicrobial immune response.
• HDT demonstrates potential efficacy against both drug-sensitive and drug-resistant pathogen strains.

Conclusions:

• Host-Directed Therapy (HDT) presents a viable alternative or complementary approach to conventional antibiotics.
• By targeting host pathways, HDT can effectively combat intracellular pathogens, including resistant strains.
• Further research into HDT is warranted to develop new treatments for challenging infectious diseases.